FDA Inspection
Romark Belgium BVBARomark Belgium BVBA – FDA Inspection, Aug 14, 2020
Record Details
This FDA Inspection record concerns Romark Belgium BVBA, with an inspection on August 14, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Romark Belgium BVBA
- Inspection Date
- August 14, 2020
- Product Type
- Drugs
View Company Profile
ID · 128e6342-9a57-487a-8fd3-ca6784ba4412
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1135007
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Romark Belgium BVBA
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 17, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Romark Belgium BVBA
- FDA Inspection 969503 - 2016-03-17
- FDA Inspection 883655 - 2014-06-13
- FDA Inspection 748191 - 2011-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.